I checked into The Vessyl, a new Costa Rica wellness resort using 4D sound, vibration and somatic practices for a nervous ...
I checked into The Vessyl, a new Costa Rica wellness resort using 4D sound, vibration and somatic practices for a nervous ...
Learn why chronic lymphocytic leukemia (CLL) causes persistent exhaustion, explore common triggers, and discover practical ...
The FDA approved Enspryng, an interleukin-6 inhibitor, for at-home subcutaneous treatment of thyroid eye disease, according ...
An updated guideline proposed several shifts in how healthcare professionals manage thyroid health for pregnant women.In May, ...
A thyroid medicine is being recalled at the FDA's highest risk level − and it's causing confusion and concern among the many Americans who use such medications to manage thyroid conditions. The recall ...
The FDA has approved Enspryng (satralizumab-mwge) for thyroid eye disease in adults, offering the first at-home subcutaneous IL-6 receptor antagonist for TED.
Nikolai Strusberg, MD, discussed other toxicities of proton vs photon breast RT, practice implications, and next steps in ...
Liza M. Cohen, MD, explains when to use CT vs MRI in thyroid eye disease and why to review images yourself.
At AAO 2026, Michael T. Yen, MD, reviewed REVEAL-1 efficacy and hearing safety data for subcutaneous elegrobart in active TED ...
Nationwide initiative brings thyroid awareness, health education, targeted TSH screening and referral closer to the community ...
Officials have classified the risk level of a thyroid medicine recall initiated last month to its most serious category. On Sept. 22, the U.S. Food and Drug Administration categorized the recall – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results